HemaSphere (Jun 2022)
S145: THE COMBINATION OF IBRUTINIB PLUS VENETOCLAX RESULTS IN A HIGH RATE OF MRD NEGATIVITY IN PREVIOUSLY UNTREATED CLL: THE RESULTS OF THE PLANNED INTERIM ANALYSIS OF THE PHASE III NCRI FLAIR TRIAL
- P. Hillmen,
- A. Pitchford,
- A. Bloor,
- A. Pettitt,
- P. Patten,
- F. Forconi,
- A. Schuh,
- C. Fox,
- N. Elmusharaf,
- S. Gatto,
- B. Kennedy,
- J. Gribben,
- N. Pemberton,
- O. Sheehy,
- G. Preston,
- D. Howard,
- A. Hockaday,
- D. Cairns,
- S. Jackson,
- N. Greatorex,
- N. Webster,
- S. Dalal,
- J. Shingles,
- K. Cwynarski,
- S. Paneesha,
- D. Allsup,
- A. Rawstron,
- T. Munir
Affiliations
- P. Hillmen
- 1 St James’s University Hospital
- A. Pitchford
- 2 Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, Leeds
- A. Bloor
- 3 University of Manchester, Manchester
- A. Pettitt
- 4 Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool
- P. Patten
- 5 King’s College Hospital, London
- F. Forconi
- 6 University of Southampton, Southampton
- A. Schuh
- 7 Oxford University Hospital NHT Trust, Oxford
- C. Fox
- 8 Nottingham University Hospitals NHS Trust, Nottingham
- N. Elmusharaf
- 9 Wales Teaching Hospital
- S. Gatto
- 10 University Hospital of Wales, Cardiff
- B. Kennedy
- 11 Leicester Royal Infirmary, Leicester
- J. Gribben
- 12 St Bartholomew’s Hospital, London
- N. Pemberton
- 13 Worcestershire Acute Hospitals NHS Trust, Worcester
- O. Sheehy
- 14 Belfast City Hospital, Belfast
- G. Preston
- 15 Aberdeen Royal Infirmary, Aberdeen
- D. Howard
- 16 Roche, Reading
- A. Hockaday
- 2 Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, Leeds
- D. Cairns
- 2 Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, Leeds
- S. Jackson
- 2 Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, Leeds
- N. Greatorex
- 2 Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, Leeds
- N. Webster
- 17 HMDS, Leeds Cancer Centre, Leeds
- S. Dalal
- 17 HMDS, Leeds Cancer Centre, Leeds
- J. Shingles
- 17 HMDS, Leeds Cancer Centre, Leeds
- K. Cwynarski
- 18 University College London, London
- S. Paneesha
- 19 Birmingham Heartlands Hospital, Birmingham
- D. Allsup
- 20 Castle Hill Hospital, Hull
- A. Rawstron
- 17 HMDS, Leeds Cancer Centre, Leeds
- T. Munir
- 21 UK NCRI CLL sub-group, Leeds, United Kingdom
- DOI
- https://doi.org/10.1097/01.HS9.0000843472.57904.29
- Journal volume & issue
-
Vol. 6
pp. 46 – 47
Abstract
No abstracts available.
